Clinical trials
Completed Phase 2/3 Lymphoma, Non-Hodgkin trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2017 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 1 |
| Chiron Corporation | 1 |
| Gamida Cell -Teva Joint Venture Ltd. | 1 |
| Rochester General Hospital | 1 |
| Roswell Park Cancer Institute | 1 |
| Universität des Saarlandes | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Myelodysplastic Syndromes | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia, Aplastic | 1 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blast Crisis | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.